Cargando…
New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatments and with adequate cost, stability, and properties are urgently needed. No antitubulin drug is currently in the clinic against Leishmania infantum, the causative agent of visceral leishmaniasis in th...
Autores principales: | González, Myriam, Alcolea, Pedro José, Álvarez, Raquel, Medarde, Manuel, Larraga, Vicente, Peláez, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142021/ https://www.ncbi.nlm.nih.gov/pubmed/34015753 http://dx.doi.org/10.1016/j.ijpddr.2021.02.006 |
Ejemplares similares
-
Temperature increase prevails over acidification in gene expression modulation of amastigote differentiation in Leishmania infantum
por: Alcolea, Pedro J, et al.
Publicado: (2010) -
Influence of the Microenvironment in the Transcriptome of Leishmania infantum Promastigotes: Sand Fly versus Culture
por: Alcolea, Pedro J., et al.
Publicado: (2016) -
Stage-specific differential gene expression in Leishmania infantum: from the foregut of Phlebotomus perniciosus to the human phagocyte
por: Alcolea, Pedro J, et al.
Publicado: (2014) -
Stable Episomal Transfectant Leishmania infantum Promastigotes Over-Expressing the DEVH1 RNA Helicase Gene Down-Regulate Parasite Survival Genes
por: Alonso, Ana, et al.
Publicado: (2022) -
Leishmania infantum UBC1 in Metacyclic Promastigotes from Phlebotomus perniciosus, a Vaccine Candidate for Zoonotic Visceral Leishmaniasis
por: Larraga, Jaime, et al.
Publicado: (2022)